A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Company Overview United Health Products, Inc. (“UHP”, “we” or the “Company”) develops, manufactures, and markets a patented hemostatic gauze for the healthcare and wound care sectors. Our gauze product, CelluSTAT®, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. We are in the process of seeking regulatory approval to sell our hemostatic gauze product line into the U.S. Class III and European CE Mark human surgical markets. We are continuing on our path to seek FDA Premarket Approval (PMA) for our CelluSTAT Hemostatic Gauze products to implement our business strategy. In March 2024, we submitted a full application for Premarket Approval to the FDA.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | - | - | - |
| Net Income | -2.9M | -2.0M | -2.6M | -1.7M | -31M | -16M |
| EPS | $-0.02 | $-0.01 | $-0.01 | $-0.01 | $-0.13 | $-0.07 |
| Free Cash Flow | 0 | -1.2M | -2.2M | -620K | -828K | -1.4M |
| ROIC | -2325.4% | -587.4% | -673.5% | -631.5% | -87848.4% | -5403.2% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | -0.23 | -0.00 | -0.00 | -0.00 | -1.23 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -2.8M | -2.0M | -2.4M | -2.8M | -30M | -15M |
| Operating Margin | 0.0% | - | - | - | - | - |
| ROE | 0.0% | - | - | - | - | - |
| Shares Outstanding | 259M | 200M | 262M | 247M | 234M | 229M |
United Health Products, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
United Health Products, Inc. (UEEC) has a market capitalization of $12M. It is classified as a small-cap stock.
United Health Products, Inc. (UEEC) does not currently pay a regular dividend.
United Health Products, Inc. (UEEC) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
United Health Products, Inc. (UEEC) generated $-1 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
United Health Products, Inc. (UEEC) reported earnings per share (EPS) of $-0.01 in its most recent fiscal year.
The Ledger Terminal provides 12 years of financial data for United Health Products, Inc. (UEEC), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
United Health Products, Inc. (UEEC) has a book value per share of $-0.01, based on its most recent annual SEC filing.
No recent press releases.